献血者选择与献血适宜性-献血年龄上限与献血间隔期调整刍议
Blood donor selection and suitability for blood donation: a discussion on adjusting the upper age limit and interval for whole blood donation
献血者筛查标准是保障献血者与受血者安全、维护血液供应充足与可及的核心环节。 百余年来,随着血库体系建立及经血传播病原体识别,健康征询、体格检查和实验室检测逐步纳入筛查流程,保障了血液服务安全、可靠且有效地运转。 而近数十年来随着科学技术不断提升,人类对于人体的认识也不断加深。 因此有必要对献血者筛查标准设置的科学性、必要性和合理性系统地进行反思和再认知。 本文作为本期全血献血间隔与献血年龄上限系列文章的导论性刍议,围绕献血者筛查标准形成与动态调整逻辑,结合本期相关专家共识及我国多中心真实世界研究概况,探讨献血安全与血液供应之间的平衡,并从政策本土化、循证施策和试点评估三个层面提出我国献血者筛查标准优化的未来方向。
Objective Blood donor selection criteria provide the core framework for assessing whether a prospective donor is suitable to donate blood, with the dual aim of protecting donor health and recipient safety while supporting a sufficient and accessible blood supply. Over the past century, with the establishment of blood banking systems and the progressive identification of transfusion-transmissible pathogens, health questionnaires, physical assessment and laboratory testing have become integral parts of the donor selection process, contributing to the safe, reliable and effective operation of blood services. In recent decades, advances in science and technology, together with a deeper understanding of human physiology, disease risk and transfusion safety, have made it necessary to systematically re-examine the scientific basis, necessity and appropriateness of existing donor selection criteria. As an introductory commentary to this series on whole-blood interdonation intervals and the upper age limit for blood donation, this article discusses the rationale underlying the establishment and dynamic adjustment of donor selection criteria. Drawing on the relevant expert consensus statements in this series and an overview of multicenter real-world studies from China, it explores the balance between donor safety and blood supply sufficiency and proposes future directions for optimizing donor selection criteria in China through local adaptation of policies, evidence-informed decision-making, and pilot evaluation.
| [1] |
WORLD HEALTH ORGANIZATION. Blood Donor Selection:Guidelines on Assessing Donor Suitability for Blood Donation[M]. Geneva: World Health Organization, 2012. |
| [2] |
WORLD HEALTH ORGANIZATION. The Melbourne Declaration on 100% voluntary non-remunerated donation of blood and blood components[R/OL].(2009-06-11)[2026-09-02].https://www.who.int/publications/m/item/the-melbourne-declaration. |
| [3] |
|
| [4] |
WHO EXPERT GROUP. Expert consensus statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD)[J].Vox Sang, 2012, 103 (4):337-342. |
| [5] |
EDER A, GOLDMAN M, ROSSMANN S, |
| [6] |
WORLD HEALTH ORGANIZATION. Safe blood and blood products:distance learning materials[M]. Geneva:World Health Organization,2002. |
| [7] |
|
| [8] |
|
| [9] |
Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation[J].Vox Sang, 2012, 103(4):337-342. |
| [10] |
EUROPEAN DIRECTORATE FOR THE QUALITY OF MEDICINES & HEALTHCARE. Guide for the preparation, use and quality assurance of blood components[M]. 22nd ed. Strasbourg:European Directorate for the Quality of Medicines & HealthCare,2025. |
| [11] |
|
| [12] |
HU W, MENG H, HU Q, |
| [13] |
巩晗实, 陈睿, 段勇, |
| [14] |
|
| [15] |
|
| [16] |
WORLD HEALTH ORGANIZATION, UNITED NATIONS CHILDREN′S FUND, UNITED NATIONS UNIVERSITY. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers[M]. Geneva:World Health Organization,2001. |
| [17] |
|
| [18] |
|
| [19] |
苏玲玲, 陈镇奇, 翁妙卿, |
| [20] |
|
| [21] |
宁理, 张艳艳, 曾劲峰, |
| [22] |
|
| [23] |
王鸿捷. 献血者铁缺乏:现状与管理[J].中国输血杂志, 2021, 34(1):1-4. |
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
马维娟, 王同显, 马保凤. 献血相关性铁缺乏及其应对策略[J].中国输血杂志, 2017, 30 (11):1307-1311. |
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
KARREGAT J, MEULENBELD A, ABUBAKAR J, |
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
IMADA H, AKITA T, SUGIYAMA A, |
| [42] |
JAPANESE RED CROSS SOCIETY. Blood services 2018[R]. Tokyo:Blood Service Headquarters, Japanese Red Cross Society,2018. |
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
伍立桃, 张艳艳, 曾劲峰, |
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
张燕华, 戴梓宁, 王同显. 延长法定献血年龄的安全性和可行性[J].中国输血杂志, 2020, 33(2):172-175. |
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
EDGREN G, ULLUM H, ROSTGAARD K, |
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
常乐, 闫颖, 姬慧敏, |
| [62] |
|
| [63] |
王瑞, 黄力勤, 张婧, |
| [64] |
|
| [65] |
国家卫生健康委临床检验中心血液筛查专家组. 中国献血者人群丙氨酸氨基转移酶血液筛查策略调整专家共识[J].中国输血杂志, 2025, 38 (4):455-465. |
| [66] |
EXPERT GROUP ON BLOOD SCREENING, NATIONAL CENTER FOR CLINICAL LABORATORIES, NATIONAL HEALTH COMMISSION. Expert consensus on the adjustment of blood screening strategy for alanine aminotransferase in Chinese blood donor population[J].Chin J Blood Transfusion, 2025, 38(4):455-465. |
| [67] |
党英男, 沙娜·哈勒木别克, 汤戎, |
| [68] |
|
| [69] |
郑欣, 薛原野, 王皓飚, |
| [70] |
|
| [71] |
|
| [72] |
国家卫生健康委员会. 血站技术操作规程(2019 版): 国卫医函〔2019〕98 号[S/OL].(2019-04-28)[2026-09-02]. https://www.nhc.gov.cn/yzygj/c100068/201905/4822b48429044e16baa2739c10fea35e. |
| [73] |
医疗财团法人台湾血液基金会. 血清转胺酶(ALT)[EB/OL].(2023-01-10)[2026-09-02]. https://www.blood.org.tw/xmdoc/cont?xsmsid=0P063552057214634886&sid=0P063610914729510051. |
| [74] |
|
| [75] |
杨柳, 李萍. 无偿献血前后血压变化规律及影响因素分析[J].实验与检验医学, 2020, 38(3):603-604. |
| [76] |
|
| [77] |
EDER A. Evidence-based selection criteria to protect blood donors[J].J Clin Apher, 2010, 25 (6):331-337. |
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
献血者健康检查之血压筛查策略专家共识编写组. 中国献血者人群献血前血压筛查策略调整的专家共识[J].中国输血杂志, 2025, 38(5):595-604. |
| [87] |
WRITING GROUP OF EXPERT CONSENSUS ON BLOOD PRESSURE SCREENING STRATEGY IN BLOOD DONOR HEALTH EXAMINATION. Expert consensus on adjustment of pre-donation blood pressure screening requirements for blood donor population in China[J].Chin J Blood Transfusion, 2025, 38(5):595-604. |
| [88] |
|
| [89] |
|
基地平台建设项目(医科院重点实验室)(2018PT32016)
/
| 〈 |
|
〉 |